14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 04, 2024 Sell 6 095 Obenshain Andrew Common Stock
Mar 04, 2024 Sell 4 573 Klima Thomas J Common Stock
Mar 01, 2024 Buy 199 000 Colvin Richard A Stock Option (right to buy)
Mar 01, 2024 Sell 6 770 Colvin Richard A Common Stock
Mar 01, 2024 Buy 199 000 Vittiglio Joseph Stock Option (right to buy)
Mar 01, 2024 Buy 650 000 Obenshain Andrew Stock Option (right to buy)
Mar 01, 2024 Buy 199 000 Krawtschuk Christopher Stock Option (right to buy)
Mar 01, 2024 Buy 199 000 Klima Thomas J Stock Option (right to buy)
Feb 05, 2024 Sell 2 714 Klima Thomas J Common Stock
Feb 05, 2024 Sell 5 217 Vittiglio Joseph Common Stock
Feb 05, 2024 Sell 1 879 Obenshain Andrew Common Stock
Jan 05, 2024 Sell 3 162 Obenshain Andrew Common Stock
Jan 05, 2024 Sell 597 Colvin Richard A Common Stock
Dec 06, 2023 Sell 4 526 Krawtschuk Christopher Common Stock
Nov 03, 2023 Sell 807 Obenshain Andrew Common Stock
Nov 02, 2023 Sell 2 343 Colvin Richard A Common Stock
Sep 05, 2023 Sell 922 Klima Thomas J Common Stock
Aug 10, 2023 Sell 16 929 Obenshain Andrew Common Stock
Jun 16, 2023 Buy 10 790 Tita-reid Najoh Common Stock
Jun 16, 2023 Buy 21 600 Tita-reid Najoh Stock Option (right to buy)
Jun 16, 2023 Buy 10 790 Agwunobi John O Common Stock
Jun 16, 2023 Buy 21 600 Agwunobi John O Stock Option (right to buy)
Jun 16, 2023 Buy 10 790 Vachon Mark Common Stock
Jun 16, 2023 Buy 21 600 Vachon Mark Stock Option (right to buy)
Jun 16, 2023 Buy 10 790 Leschly Nick Common Stock
Jun 16, 2023 Buy 21 600 Leschly Nick Stock Option (right to buy)
Jun 16, 2023 Buy 10 790 Leiderman Elisabeth Common Stock
Jun 16, 2023 Buy 21 600 Leiderman Elisabeth Stock Option (right to buy)
Jun 16, 2023 Buy 21 600 Jones-burton Charlotte Stock Option (right to buy)
Jun 16, 2023 Buy 10 790 Jones-burton Charlotte Common Stock
Jun 02, 2023 Sell 4 130 Klima Thomas J Common Stock
Apr 03, 2023 Buy 0 Paulson Richard A.
Apr 03, 2023 Buy 7 500 Paulson Richard A. Stock Options (Right to buy)
Apr 03, 2023 Buy 4 663 Paulson Richard A. Common Stock
Mar 01, 2023 Buy 55 000 Colvin Richard A Common Stock
Mar 01, 2023 Buy 110 000 Colvin Richard A Stock Option (right to buy)
Mar 01, 2023 Buy 338 000 Obenshain Andrew Stock Option (right to buy)
Mar 01, 2023 Buy 67 600 Obenshain Andrew Common Stock
Mar 01, 2023 Buy 55 000 Klima Thomas J Common Stock
Mar 01, 2023 Buy 110 000 Klima Thomas J Stock Option (right to buy)
Feb 01, 2023 Sell 2 260 Klima Thomas J Common Stock
Feb 01, 2023 Sell 1 153 Colvin Richard A Common Stock
Feb 01, 2023 Sell 1 420 Obenshain Andrew Common Stock
Feb 01, 2023 Buy 100 000 Vittiglio Joseph Stock Options (Right to buy)
Feb 01, 2023 Buy 50 000 Vittiglio Joseph Common Stock
Jan 11, 2023 Sell 3 178 Obenshain Andrew Common Stock
Jan 11, 2023 Sell 557 Colvin Richard A Common Stock
Jan 11, 2023 Sell 4 290 Leschly Nick Common Stock
Jan 03, 2023 Buy 0 Vittiglio Joseph
Jan 03, 2023 Buy 0 Vittiglio Joseph
Dec 01, 2022 Buy 100 000 Krawtschuk Christopher Stock Options (Right to buy)
Dec 01, 2022 Buy 50 000 Krawtschuk Christopher Common Stock
Nov 07, 2022 Buy 0 Krawtschuk Christopher
Nov 07, 2022 Buy 0 Krawtschuk Christopher
Nov 04, 2022 Sell 218 Colvin Richard A Common Stock
Nov 04, 2022 Sell 1 263 Obenshain Andrew Common Stock
Nov 01, 2022 Buy 30 000 Colvin Richard A Common Stock
Nov 01, 2022 Buy 60 000 Colvin Richard A Stock Options (Right to buy)
Oct 17, 2022 Sell 1 004 Leiderman Elisabeth Common Stock
Sep 01, 2022 Buy 22 000 Klima Thomas J Stock Option (right to buy)
Aug 22, 2022 Buy 0 Colvin Richard A Common Stock
Aug 22, 2022 Buy 0 Colvin Richard A Common Stock
Aug 22, 2022 Buy 0 Colvin Richard A Common Stock
Aug 22, 2022 Buy 0 Colvin Richard A Common Stock
Aug 22, 2022 Buy 0 Colvin Richard A Common Stock
Aug 22, 2022 Buy 0 Colvin Richard A Common Stock
Aug 22, 2022 Buy 40 153 Colvin Richard A Stock Options (Right to buy)
Aug 22, 2022 Buy 26 400 Colvin Richard A Stock Options (Right to buy)
Aug 22, 2022 Buy 11 134 Colvin Richard A Stock Options (Right to buy)
Aug 22, 2022 Buy 4 429 Colvin Richard A Stock Options (Right to buy)
Aug 22, 2022 Buy 8 030 Colvin Richard A Stock Options (Right to buy)
Aug 19, 2022 Sell 14 194 Cole Jason Common Stock
Aug 04, 2022 Sell 7 448 Cole Jason Common Stock
Aug 04, 2022 Sell 21 805 Obenshain Andrew Common Stock
Jul 12, 2022 Sell 1 358 Eggimann Anne-virginie Common Stock
Jun 22, 2022 Buy 3 109 Jones-burton Charlotte Common Stock
Jun 22, 2022 Buy 3 109 Leschly Nick Common Stock
Jun 22, 2022 Buy 7 000 Vachon Mark Stock Option (right to buy)
Jun 22, 2022 Buy 5 000 Agwunobi John O Stock Option (right to buy)
Jun 22, 2022 Buy 3 109 Leiderman Elisabeth Common Stock
Jun 22, 2022 Buy 5 000 Tita-reid Najoh Stock Option (right to buy)
Jun 03, 2022 Sell 3 753 Klima Thomas J Common Stock
Mar 07, 2022 Buy 4 663 Jones-burton Charlotte Common Stock
Mar 07, 2022 Buy 0 Jones-burton Charlotte No Securities are beneficially owned
Feb 01, 2022 Buy 18 000 Obenshain Andrew Common Stock
Feb 01, 2022 Buy 90 000 Obenshain Andrew Stock Option (right to buy)
Feb 01, 2022 Buy 17 000 Eggimann Anne-virginie Common Stock
Feb 01, 2022 Buy 34 000 Eggimann Anne-virginie Stock Option (right to buy)
Feb 01, 2022 Buy 7 500 Whitten Jessica Common Stock
Feb 01, 2022 Buy 15 000 Whitten Jessica Stock Option (right to buy)
Feb 01, 2022 Buy 25 000 Consylman Gina Common Stock
Feb 01, 2022 Buy 50 000 Consylman Gina Stock Option (right to buy)
Feb 01, 2022 Buy 25 000 Klima Thomas J Common Stock
Feb 01, 2022 Buy 50 000 Klima Thomas J Stock Option (right to buy)
Feb 01, 2022 Buy 25 000 Cole Jason Common Stock
Feb 01, 2022 Buy 50 000 Cole Jason Stock Option (right to buy)
Jan 11, 2022 Buy 0 Eggimann Anne-virginie Common Stock
Jan 11, 2022 Buy 0 Eggimann Anne-virginie Common Stock
Jan 11, 2022 Buy 0 Eggimann Anne-virginie Common Stock
Jan 11, 2022 Buy 0 Eggimann Anne-virginie Common Stock
INSIDER POWER
87.162
Last 100 transactions
Buy: 3 327 739 | Sell: 124 565 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 87.162.

In total, the insiders bought 3 327 739 and sold 124 565 BLUE shares in the last 100 trades.

Click to get the best stock tips daily for free!

About bluebird bio

bluebird bio bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clini... BLUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT